Scarica l'app Stockscreener
4.23
4.30%
-0.19
Pre-mercato:
4.11
-0.12
-2.84%
Precedente Chiudi:
$4.42
Aprire:
$4.49
Volume 24 ore:
65,048
Relative Volume:
0.73
Capitalizzazione di mercato:
$38.27M
Reddito:
$442.00K
Utile/perdita netta:
$-30.46M
Rapporto P/E:
-0.9484
EPS:
-4.46
Flusso di cassa netto:
$-27.47M
1 W Prestazione:
-0.70%
1M Prestazione:
+64.59%
6M Prestazione:
-2.98%
1 anno Prestazione:
-43.39%
Intervallo 1D:
$4.16
$4.49
Intervallo di 1 settimana:
$4.01
$4.62
Portata 52W:
$2.2801
$8.396
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Confronta CLNN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
4.23 | 38.27M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
25.75 | 31.47B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
14.00 | 30.77B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
GIS
General Mills Inc
|
53.08 | 29.84B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
80.23 | 28.25B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
72.96 | 20.27B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Clene Regains Nasdaq Compliance as of June 2025 - TipRanks
Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat
Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat
Nanotechnology Stocks To Watch NowJune 14th - MarketBeat
Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat
Best Nanotechnology Stocks To Follow Now – June 13th - Defense World
Clene Inc. (NASDAQ:CLNN) Receives $40.00 Average Target Price from Analysts - Defense World
Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat
Nanotechnology Stocks To ResearchJune 8th - MarketBeat
Clene (NASDAQ:CLNN) Trading Down 0.7% – Should You Sell? - Defense World
Clene Inc. CEO to Share Company Updates at Investor Summit Virtual - citybuzz -
Clene Inc. Chief Executive Officer Rob Etherington to Present at - GuruFocus
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 | CLNN Stock News - GuruFocus
Clene CEO Rob Etherington Set to Reveal Company Updates at Investor Summit Virtual Conference - Stock Titan
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - The Globe and Mail
Clene Inc. (CLNN) Executives to Host Meeting with Maxim | CLNN S - GuruFocus
Clene management to meet with Maxim - TipRanks
Nanomedicines Market Booming Worldwide: Growth Trends, - openPR.com
Clene Inc. shareholder General Resonance sells $2,472 in stock - Investing.com
Best Nanotechnology Stocks To Follow Today – May 31st - Defense World
Clene Inc. shareholder General Resonance sells $2,472 in stock By Investing.com - Investing.com UK
Clene Inc.: General Resonance LLC sells $1,148 in common stock By Investing.com - Investing.com Nigeria
Clene Inc.: General Resonance LLC sells $1,148 in common stock - Investing.com
Clene inc. sees $1,089 stock sale by major shareholder - Investing.com South Africa
Clene Approves Stock Plan Amendment at Annual Meeting - TipRanks
Clene stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa
Clene stock touches 52-week low at $2.5 amid market challenges - Investing.com Australia
Brokerages Set Clene Inc. (NASDAQ:CLNN) Target Price at $40.00 - Defense World
Clene eyeing regulatory submission for CNM-Au8 in ALS by year’s end - ALS News Today
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates - MSN
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Roth Capital Has Optimistic Outlook of Clene Q2 Earnings - Defense World
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $33.00 - Defense World
D. Boral Capital Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures - TipRanks
Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter
Clene Inc. Advances CNM-Au8 Treatment for ALS, Reports Promising Q1 Results - citybuzz -
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS - citybuzz -
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating - TipRanks
Clene (CLNN) Maintains Buy Rating Despite Price Target Reduction | CLNN Stock News - GuruFocus
Clene (CLNN) Stock Rating and Price Target Maintained at Buy | C - GuruFocus
Renaissance Technologies LLC Invests $96,000 in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. to Showcase Neurodegenerative Research at D. Boral Capital Global Conference - citybuzz -
Clene (CLNN) Reports Decline in Cash Reserves | CLNN Stock News - GuruFocus
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits - TipRanks
Clene (CLNN) Exceeds Revenue Expectations and Advances ALS Research | CLNN Stock News - GuruFocus
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference | CLNN Stock News - GuruFocus
Clene Inc. SEC 10-Q Report - TradingView
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
Geode Capital Management LLC Grows Stake in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clene Inc Azioni (CLNN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| General Resonance LLC | 10% Owner |
Jun 02 '25 |
Sale |
4.12 |
600 |
2,473 |
708,592 |
| General Resonance LLC | 10% Owner |
May 30 '25 |
Sale |
2.80 |
410 |
1,148 |
709,192 |
| General Resonance LLC | 10% Owner |
May 29 '25 |
Sale |
2.73 |
410 |
1,119 |
709,602 |
| General Resonance LLC | 10% Owner |
May 28 '25 |
Sale |
2.60 |
420 |
1,090 |
710,012 |
| General Resonance LLC | 10% Owner |
May 27 '25 |
Sale |
2.45 |
420 |
1,029 |
710,432 |
| General Resonance LLC | 10% Owner |
Mar 19 '25 |
Sale |
4.40 |
1,400 |
6,160 |
710,852 |
| General Resonance LLC | 10% Owner |
Mar 18 '25 |
Sale |
4.45 |
1,333 |
5,932 |
712,252 |
| MATLIN DAVID J | Director |
Sep 30 '24 |
Buy |
4.75 |
92,307 |
438,458 |
444,491 |
| Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
| Etherington Robert Dee | Chief Executive Officer |
Sep 30 '24 |
Buy |
4.75 |
10,000 |
47,500 |
40,149 |
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):